Please turn JavaScript on
STAT icon

STAT

Subscribe to STAT’s news feed.

Click on “Follow” and decide if you want to get news from STAT via RSS, as email newsletter, via mobile or on your personal news page.

Subscription to STAT comes without risk as you can unsubscribe instantly at any time.

You can also filter the feed to your needs via topics and keywords so that you only receive the news from STAT which you are really interested in. Click on the blue “Filter” button below to get started.

Website title: STAT | Reporting from the frontiers of health and medicine

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  9.62 / day

Message History

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.

Hello! Wanna drop some cars in an open pasture? The internet does it ...


Read full story

Sarepta Therapeutics, the bruised maker of Duchenne muscular dystrophy treatments, on Monday named Michael Severino, formerly the CEO of Tessera Therapeutics, as its new chief executive, starting Tuesday. 

Severino is replacing Doug Ingram, who


Read full story

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-too-familiar routine of meetings, deadlines, and the like has returned with a vengeance. You knew this would happen, yes? To cope, we are relying, as always, on a cuppa stimulation. Our choice today is Earl Grey, an old standby. Feel free to j...


Read full story

The Food and Drug Administration said Monday that Capricor Therapeutics’ stem cell treatment for Duchenne muscular dystrophy did not  meet the objectives of Phase 3 trial — contrary to the company’s claim...


Read full story

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.

Good morning. In a search for silver linings yesterday, I found this: I can finally spell the word “diarrhea” confidently! The latest...


Read full story